Chicoric acid analogues as HIV-1 integrase inhibitors

被引:143
作者
Lin, ZW
Neamati, N
Zhao, H
Kiryu, Y
Turpin, JA
Aberham, C
Strebel, K
Kohn, K
Witvrouw, M
Pannecouque, C
Debyser, Z
De Clercq, E
Rice, WG
Pommier, Y
Burke, TR
机构
[1] NCI, Med Chem Lab, Div Basic Sci, NIH, Bethesda, MD 20892 USA
[2] NCI, Mol Pharmacol Lab, Div Basic Sci, NIH, Bethesda, MD 20892 USA
[3] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA
[4] NCI, Lab Antiviral Drug Mechanisms, Frederick Canc Res & Dev Ctr, SAIC Frederick, Frederick, MD 21702 USA
[5] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
关键词
D O I
10.1021/jm980531m
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The present study was undertaken to examine structural features of L-chicoric acid (3) which are important for potency against purified HIV-1 integrase and for reported cytoprotective effects in cell-based systems. Through a progressive series of analogues, it was shown that enantiomeric D-chicoric acid (4) retains inhibitory potency against purified integrase equal to its L-counterpart and further that removal of either one or both carboxylic functionalities results in essentially no loss of inhibitory potency. Additionally, while two caffeoyl moieties are required, attachment of caffeoyl groups to the central linking structure can be achieved via amide or mixed amide/ester linkages. More remarkable is the finding that blockage of the catechol functionality through conversion to tetraacetate esters results in almost no loss of potency, contingent on the presence of at least one carboxyl group on the central linker. Taken as a whole, the work has resulted in the identification of new integrase inhibitors which may be regarded as bis-caffeoyl derivatives of glycidic acid and amino acids such as serine and beta-aminoalanine. The present study also examined the reported ability of chicoric acid to exert cytoprotective effects in HIV-infected cells. It was demonstrated in target and cell-based assays that the chicoric acids do not significantly inhibit other targets associated with HIV-1 replication, including reverse transcription, protease function, NCp7 zinc finger function, or replication of virus from latently infected cells. In CEM cells, for both the parent chicoric acid and selected analogues, antiviral activity was observable under specific assay conditions and with high dependence on the multiplicity of viral infection. However, against HIV-1- and HIV-2-infected MT-4 cells, the chicoric acids and their tetraacetylated esters exhibited antiviral activity (50% effective concentration (EC(50)) ranging from 1.7 to 20 mu M and 50% inhibitory concentration (IC(50)) ranging from 40 to 60 mu M).
引用
收藏
页码:1401 / 1414
页数:14
相关论文
共 44 条
[11]   MULTIPLE EFFECTS OF MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE ON VIRAL REPLICATION [J].
ENGELMAN, A ;
ENGLUND, G ;
ORENSTEIN, JM ;
MARTIN, MA ;
CRAIGIE, R .
JOURNAL OF VIROLOGY, 1995, 69 (05) :2729-2736
[12]   INHIBITION OF HIV-1 INTEGRASE BY FLAVONES, CAFFEIC ACID PHENETHYL ESTER (CAPE) AND RELATED-COMPOUNDS [J].
FESEN, MR ;
POMMIER, Y ;
LETEURTRE, F ;
HIROGUCHI, S ;
YUNG, J ;
KOHN, KW .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (03) :595-608
[13]   INVITRO ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ACTIVITIES OF TRANSITION-STATE MIMETIC HIV PROTEASE INHIBITORS CONTAINING ALLOPHENYLNORSTATINE [J].
KAGEYAMA, S ;
MIMOTO, T ;
MURAKAWA, Y ;
NOMIZU, M ;
FORD, H ;
SHIRASAKA, T ;
GULNIK, S ;
ERICKSON, J ;
TAKADA, K ;
HAYASHI, H ;
BRODER, S ;
KISO, Y ;
MITSUYA, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (04) :810-817
[14]   THE AVIAN RETROVIRAL IN PROTEIN IS BOTH NECESSARY AND SUFFICIENT FOR INTEGRATIVE RECOMBINATION INVITRO [J].
KATZ, RA ;
MERKEL, G ;
KULKOSKY, J ;
LEIS, J ;
SKALKA, AM .
CELL, 1990, 63 (01) :87-95
[15]   A new flavonol glycoside gallate ester from Acer okamotoanum and its inhibitory activity against human immunodeficiency virus-1 (HIV-1) integrase [J].
Kim, HJ ;
Woo, ER ;
Shin, CG ;
Park, H .
JOURNAL OF NATURAL PRODUCTS, 1998, 61 (01) :145-148
[16]   DETECTION OF REPLICATION-COMPETENT AND PSEUDOTYPED HUMAN-IMMUNODEFICIENCY-VIRUS WITH A SENSITIVE CELL-LINE ON THE BASIS OF ACTIVATION OF AN INTEGRATED BETA-GALACTOSIDASE GENE [J].
KIMPTON, J ;
EMERMAN, M .
JOURNAL OF VIROLOGY, 1992, 66 (04) :2232-2239
[17]   Resistance to the anti-human immunodeficiency virus type 1 compound L-chicoric acid results from a single mutation at amino acid 140 of integrase [J].
King, PJ ;
Robinson, WE .
JOURNAL OF VIROLOGY, 1998, 72 (10) :8420-8424
[18]   INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS INTEGRASE BY BIS-CATECHOLS [J].
LAFEMINA, RL ;
GRAHAM, PL ;
LEGROW, K ;
HASTINGS, JC ;
WOLFE, A ;
YOUNG, SD ;
EMINI, EA ;
HAZUDA, DJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) :320-324
[19]   REQUIREMENT OF ACTIVE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE ENZYME FOR PRODUCTIVE INFECTION OF HUMAN T-LYMPHOID CELLS [J].
LAFEMINA, RL ;
SCHNEIDER, CL ;
ROBBINS, HL ;
CALLAHAN, PL ;
LEGROW, K ;
ROTH, E ;
SCHLEIF, WA ;
EMINI, EA .
JOURNAL OF VIROLOGY, 1992, 66 (12) :7414-7419
[20]   INHIBITION OF HIV-INFECTION BY CAFFEOYLQUINIC ACID-DERIVATIVES [J].
MAHMOOD, N ;
MOORE, PS ;
DETOMMASI, N ;
DESIMONE, F ;
COLMAN, S ;
HAY, AJ ;
PIZZA, C .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1993, 4 (04) :235-240